Bristol-Myers Squibb (BMY) reported Q4 non-GAAP earnings Thursday of $1.67 per diluted share, down from $1.70 a year earlier.
Analysts polled by FactSet expected $1.46.
Revenue for the quarter ended Dec. 31 was $12.34 billion, compared with $11.48 billion a year earlier.
Analysts polled by FactSet expected $11.57 billion.
The company said it expects 2025 adjusted EPS of $6.55 to $6.85. Analysts polled by FactSet expect $6.91.
Bristol-Myers Squibb said it expects revenue of about $45.5 billion. Analysts polled by FactSet expect $46.29 billion.
Bristol-Myers Squibb shares were down 3% in recent premarket activity Thursday.
Price: 57.94, Change: -1.77, Percent Change: -2.69
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。